It took less than five months for the Zaoui brothers, star bankers of the City, to identify their prey.
Last July, Odyssey, their Spac dedicated to health, raised 300 million euros when it went public in Amsterdam with the objective of building a “
European nugget on the borders of health and tech
”.
Read also
A Spac dedicated to health goes public in Amsterdam
Associated with Jean Raby, ex-director of Natixis IM, with Michel Combes, president of Softbank International, and with Olivier Brandicourt, former boss of Sanofi, they set their sights on BenevolentAI, an English biotech specializing in artificial intelligence created in 2013. The operation values the company 1.5 billion euros.
Which makes it the most important “deal” ever concluded by a Spac in Europe.
Spacs (Special Purpose Acquisition Company) are companies with no operational activity whose securities are issued on a stock market with a view to future acquisition or merger.
And this, within two years of their creation.
The lifting record becomes
This article is for subscribers only.
You have 61% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
